These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18380600)

  • 1. HIV care and treatment for children in resource-limited settings.
    Callens SF; McKellar MS; Colebunders R
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):181-90. PubMed ID: 18380600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equity and efficiency in scaling up access to HIV-related interventions in resource-limited settings.
    Cleary S
    Curr Opin HIV AIDS; 2010 May; 5(3):210-4. PubMed ID: 20539076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Chinese free antiretroviral treatment program: challenges and responses.
    Zhang F; Haberer JE; Wang Y; Zhao Y; Ma Y; Zhao D; Yu L; Goosby EP
    AIDS; 2007 Dec; 21 Suppl 8():S143-8. PubMed ID: 18172383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early treatment of HIV: implications for resource-limited settings.
    Hobbs CV; Essajee SM
    Curr Opin HIV AIDS; 2009 May; 4(3):222-31. PubMed ID: 19532054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health systems and access to antiretroviral drugs for HIV in Southern Africa: service delivery and human resources challenges.
    Schneider H; Blaauw D; Gilson L; Chabikuli N; Goudge J
    Reprod Health Matters; 2006 May; 14(27):12-23. PubMed ID: 16713875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combining prevention, treatment and care: lessons from South Africa.
    Achmat Z; Simcock J
    AIDS; 2007 Jul; 21 Suppl 4():S11-20. PubMed ID: 17620746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertically acquired paediatric HIV infection: the challenges of providing comprehensive packages of care in resource-limited settings.
    Little KE; Bland RM; Newell ML
    Trop Med Int Health; 2008 Sep; 13(9):1098-110. PubMed ID: 18664240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral therapy for pediatric and adolescent HIV.
    Terriff CM; Synoground G
    J Sch Nurs; 1998 Apr; 14(2):36-46. PubMed ID: 9611572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chapter 3: management of TB in the HIV-infected child.
    ;
    Int J Tuberc Lung Dis; 2006 Dec; 10(12):1331-6. PubMed ID: 17167948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New challenges in therapeutic management of human immunodeficiency virus-infected children].
    Faye A
    Arch Pediatr; 2007 Feb; 14(2):212-8. PubMed ID: 17222540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scale-up of HIV care and treatment: can it transform healthcare services in resource-limited settings?
    El-Sadr WM; Abrams EJ
    AIDS; 2007 Oct; 21 Suppl 5():S65-70. PubMed ID: 18090271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The public health approach to antiretroviral treatment (ART) service scale-up in Ethiopia: the first two years of free ART, 2005-2007.
    Assefa Y; Kloos H
    Ethiop Med J; 2008 Oct; 46(4):401-6. PubMed ID: 19271406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiretroviral drug development: the challenge of cost and access.
    Dunne M
    AIDS; 2007 Jul; 21 Suppl 4():S73-9. PubMed ID: 17620756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model.
    Scott S; Mossong J; Moss WJ; Cutts FT; Cousens S
    Int J Epidemiol; 2008 Apr; 37(2):356-67. PubMed ID: 18234739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric HIV infection: the state of antiretroviral therapy.
    McKellar MS; Callens SF; Colebunders R
    Expert Rev Anti Infect Ther; 2008 Apr; 6(2):167-80. PubMed ID: 18380599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HIV infection: Which therapeutical challenges remain in 2009?].
    Rouzioux C
    Ann Pharm Fr; 2010 Jan; 68(1):44-6. PubMed ID: 20176162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.